IMRX

Immuneering Corporation Class A Common Stock

4.48

USD

+0.02

+0.45%

Sep 18, 15:58 UTC -4

Closed

After-Market

4.41

-0.07

-1.56%

IMRX Earnings Reports

Positive Surprise Ratio

IMRX beat 16 of 21 last estimates.

76%

Next Report

Date of Next Report

Estimate for Q-- -- (Revenue/ EPS)

Implied change from Q2 26 (Revenue/ EPS)

Implied change from Q-- -- (Revenue/ EPS)

Immuneering Corporation Class A Common Stock earnings per share and revenue

On Aug 05, 2026, IMRX reported earnings of -0.27 USD per share (EPS) for Q2 26, beating the estimate of -0.27 USD, resulting in a 1.24% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -0.23% price change (close before vs. close after earnings).

Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

enGene Therapeutics Inc. Common Stock

Report Date

Sep 08, 2026 For Q3 26

Estimate

-$0.43

Actual

-$0.47

Surprise

-7.16%

Anixa Biosciences, Inc.

Report Date

Sep 09, 2026 For Q3 26

Estimate

-$0.08

Actual

-$0.08

Surprise

+8.78%

Alzamend Neuro, Inc. Common Stock

Report Date

Sep 10, 2026 For Q1 27

Estimate

-$0.57

Actual

-$0.68

Surprise

-19.05%

FAQ

What were Immuneering Corporation Class A Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Immuneering Corporation Class A Common Stock reported EPS of -$0.27, beating estimates by 1.24%, and revenue of $0.00, 0% as expectations.

How did the market react to Immuneering Corporation Class A Common Stock's Q2 2026 earnings?

The stock price moved down -0.23%, changed from $4.40 before the earnings release to $4.39 the day after.

When is Immuneering Corporation Class A Common Stock expected to report next?

The next earning report is scheduled for --.

What are the forecasts for Immuneering Corporation Class A Common Stock's next earnings report?

Based on -- analysts, Immuneering Corporation Class A Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.